Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29424183 | 0.90 | MMP2 (0.61) | MMP2OPRK1OPRM1OPRD1 | |
| SCHEMBL2515519 | 0.89 | CTSD (0.54) | MMP2OPRK1 | |
| SCHEMBL30974493 | 0.89 | BACE1 (0.54) | MMP2 | |
| SCHEMBL2515525 | 0.89 | CTSD (0.54) | MMP2OPRK1 | |
| SCHEMBL9488073 | 0.89 | CTSD (0.54) | MMP2OPRK1 | |
| SCHEMBL7586807 | 0.88 | OPRD1 (0.55) | MMP2OPRK1OPRM1OPRD1 | |
| SCHEMBL7586788 | 0.88 | OPRD1 (0.55) | MMP2OPRK1OPRM1OPRD1 | |
| SCHEMBL10379929 | 0.88 | GNPAT (0.54) | MMP2OPRK1 | |
| SCHEMBL10379927 | 0.88 | GNPAT (0.54) | MMP2OPRK1 | |
| SCHEMBL29496478 | 0.87 | MMP2 (0.54) | MMP2OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008820-A1 | ENHANCED PEPTIDE CONSTRUCTS FOR ALBUMIN BINDING | FARBER MICHAEL (US) | 2026-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008820-A1 | ENHANCED PEPTIDE CONSTRUCTS FOR ALBUMIN BINDING | ALB, SHBG, MDK | MMP2 3579/4885OPRK1 771/4885OPRM1 1749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.